KEYNOTE FINANCIAL SERVICES LLC

Position in CELU — Celularity Inc

CIK 2026127 VERNON, CT

Position in CELU

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$17,892

-$21,103 QoQ

Shares Held

29,920

+2.0% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#12

of 39 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

KEYNOTE FINANCIAL SERVICES LLC holds $1,711,866 across 4 Biotechnology names. CELU ranks #4 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,339	$834,920
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,207	$599,553
3	CRSP	CRISPR Therapeutics AG	4,758	$259,501
4	CELU	Celularity Inc This page	29,920	$17,892

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,892	29,920	+2.0%	Shares	Sole	2026-08-03
2026-03-31	$38,995	29,320	+15.8%	Shares	Sole	2026-05-13
2025-12-31	$28,105	25,320	+3.4%	Shares	Sole	2026-02-13
2025-09-30	$50,673	24,480	+4.3%	Shares	Sole	2025-10-31
2025-06-30	$46,020	23,480	-6.2%	Shares	Sole	2025-08-07
2025-03-31	$43,289	25,023	0.0%	Shares	Sole	2025-05-09
2024-12-31	$52,047	25,023	+90.1%	Shares	Sole	2025-02-05
2024-09-30	$39,085	13,160	0.0%	Shares	Sole	2024-10-31
2024-06-30	$41,190	13,160	-15.5%	Shares	Sole	2024-07-24
2024-03-31	$81,410	15,566	—	Shares	Sole	2024-06-13
No filing history on record for this holder in this stock.